Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival

por Suidan, Anna May, Roisman, Laila, Belilovski Rozenblum, Anna, Ilouze, Maya, Dudnik, Elizabeth, Zer, Alona, Peled, Nir
Publicado 2019

Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer

por Kian, Waleed, Roisman, Laila C., Wallach, Nadav, Levitas, Dina, Yakobson, Alexander, Dudnik, Yulia, Peled, Nir, Rouvinov, Keren
Publicado 2020

Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib

por Kian, Waleed, Krayim, Bilal, Alsana, Hadel, Giles, Betsy, Purim, Ofer, Alguayn, Wafeek, Alguayn, Farouq, Peled, Nir, Roisman, Laila C.
Publicado 2023

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

por Goldstein, Iris M, Roisman, Laila C, Keren-Rosenberg, Shoshana, Dudnik, Julia, Nechushtan, Hovav, Shelef, Ilan, Fuchs, Vered, Kian, Waleed, Peled, Nir
Publicado 2020

Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer

por Kian, Waleed, Levitas, Dina, Alguayn, Wafeek, Shalata, Walid, Sharb, Adam A., Levin, Daniel, Roisman, Laila C., Tokar, Margarita, Peled, Nir, Yakobson, Alexander
Publicado 2020

Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer

por Roisman, Laila C., Kian, Waleed, Anoze, Alaa, Fuchs, Vered, Spector, Maria, Steiner, Roee, Kassel, Levi, Rechnitzer, Gilad, Fried, Iris, Peled, Nir, Bogot, Naama R.
Publicado 2023

NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs

por Iraqi, Muhammed, Bolel, Priyanka, Sarkar, Rhitajit, Bhattacharya, Baisali, Abu Ahmad, Muhammad, Edri, Avishay, Roisman, Laila C., Elkabets, Moshe, Shalata, Walid, Peled, Nir, Porgador, Angel
Publicado 2022

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)

por Shalata, Walid, Iraqi, Muhammed, Bhattacharya, Baisali, Fuchs, Vered, Roisman, Laila C., Cohen, Ahron Yehonatan, Massalha, Ismaell, Yakobson, Alexander, Prasad, Manu, Elkabets, Moshe, Porgador, Angel, Peled, Nir
Publicado 2021

N-Methylpurine DNA Glycosylase and OGG1 DNA Repair Activities: Opposite Associations With Lung Cancer Risk

por Leitner-Dagan, Yael, Sevilya, Ziv, Pinchev, Mila, Kramer, Ran, Elinger, Dalia, Roisman, Laila C., Rennert, Hedy S., Schechtman, Edna, Freedman, Laurence, Rennert, Gad, Livneh, Zvi, Paz-Elizur, Tamar
Publicado 2012

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing

por Sehayek, Or, Kian, Waleed, Onn, Amir, Stoff, Ronen, Sorotsky, Hadas Gantz, Zemel, Melanie, Bar, Jair, Dudnik, Yulia, Nechushtan, Hovav, Rottenberg, Yakir, Soussan-Gutman, Lior, Dvir, Addie, Roisman, Laila C., Peled, Nir
Publicado 2022

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy

por Yakobson, Alexander, Alguayn, Wafeek, Shalata, Walid, Levin, Daniel, Kian, Tawfeek A., Korngreen, Amir, Gibbs, Rachel, Salah, Mahmuod A., Samueli, Benzion, Lavrenkov, Konstantin, Roisman, Laila C., Dudnik, Yulia, Peled, Nir, Refaely, Yael, Kian, Waleed
Publicado 2021

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer

por Kian, Waleed, Christopoulos, Petros, Remilah, Areen A., Levison, Esther, Dudnik, Elizabeth, Shalata, Walid, Krayim, Bilal, Marei, Ranin, Yakobson, Alexander, Faehling, Martin, Kahala, Dolev, Sara Granot, Inbal, Levitas, Dina, Peled, Nir, Roisman, Laila C.
Publicado 2022

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

por Peled, Nir, Kian, Waleed, Inbar, Edna, Goldstein, Iris M, Zemel, Melanie, Rotem, Ofer, Rozenblum, Anna B, Nechushtan, Hovav, Dudnik, Elizabeth, Levin, Daniel, Zer, Alona, Keren-Rosenberg, Shoshana, Yust-Katz, Shlomit, Fuchs, Vered, Remilah, Areen A, Shelef, Ilan, Roisman, Laila C
Publicado 2021

Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study

por Kian, Waleed, Zemel, Melanie, Kestenbaum, Emily H., Rouvinov, Keren, Alguayn, Wafeek, Levitas, Dina, Ievko, Anna, Michlin, Regina, Abod, Moataz A., Massalha, Ismaell, Chernomordikov, Elena, Sharb, Adam A., Shalata, Walid, Levison, Esther, Roisman, Laila C., Lavrenkov, Konstantin, Peled, Nir, Nesher, Lior, Yakobson, Alexander
Publicado 2022

Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors

por Riess, Jonathan W., Rahman, Shaila, Kian, Waleed, Edgerly, Claire, Heilmann, Andreas M., Madison, Russell, Ramkissoon, Shakti H., Klaitman, Shai Shlomi, Chung, Jon H., Trabucco, Sally E., Jin, Dexter X., Alexander, Brian M., Klempner, Samuel J., Albacker, Lee A., Frampton, Garrett M., Roisman, Laila C., Miller, Vincent A., Ross, Jeffrey S., Schrock, Alexa B., Gregg, Jeffrey P., Peled, Nir, Sokol, Ethan S., Ali, Siraj M.
Publicado 2021